Remote
Associate Director, Cell Therapy Non-Personal Promotions
About this role
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches.
As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc.
or ts subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com . Overview The Associate Director, Cell Therapy Non-Personal Promotions will oversee the management and execution of non-personal promotion (NPP) content for both HCP and patient audiences, ensuring cohesive, high-impact engagement across digital channels.
This role also offers the opportunity to build and scale best-in-class digital engagement models in close partnership with Brand HCP and Patient business leads, Insights, and agency teams. Specific Responsibilities Support non-personal promotion (NPP) omnichannel execution while identifying and designing integrated engagement opportunities aligned to customer insights, audience segmentation, and brand objectives. Partner with both HCP and Patient Marketing business leads to understand engagement strategy, objectives, market research, and key priorities.